Regulatory

Regulatory  ·  Weekly digest 13 to 19 july
FDA Grants Fast Track Designation to 9MW2821 for the Treatment of Patients with Locally Advanced or Metastatic Nectin-4 Positive TNBC

Weekly Digest – July 2024 Weekly Digest – July 2024 12 July 2024: FDA Grants Fast Track Designation to 9MW2821 for the Treatment of Patients with Locally Advanced or Metastatic Nectin-4 Positive TNBC Mabwell’s 9MW2821, an innovative Nectin-4-targeting ADC, has […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly digest 13 to 19 july
FDA Grants Orphan Drug Designation to 7MW3711

Weekly Digest – July 2024 Weekly Digest – July 2024 16 July 2024: FDA Grants Orphan Drug Designation to 7MW3711 Mabwell announced that its novel B7-H3-targeting ADC, 7MW3711 received an Orphan Drug Designation from the U.S. FDA for treating Small-Cell Lung […]

by Sandhya Ramalingam

Continue Reading